Brind.

Ocugen announced it will participate in the Biotech on Tap 2025 conference.

2 reports, 1 independent Updated Sep 2

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ocugen announced it will participate in the Biotech on Tap 2025 conference.

Who's involved

What this event is mainly about

Ocugen Munich

How it developed

Newest first. Tap a step to see who reported it.

Sep 2Ocugen confirmed participation in Biotech on Tap 2025.1 source
- GlobeNewswire
Aug 13Positive scientific advice received from EMA regarding OCU410ST.1 source
- GlobeNewswire

Keep exploring

The entities involved

Ocugen
biopharmaceutical company

Nothing else this week.
Munich
capital and most populous city of Bavaria, Germany
- Nathif Adan Jama presented and published AMALFI results at the European Society of Cardiology.Sun 02:55
- Culinary traditions inspired by Munich were noted in Manila on September 1, 2026.Thu 18:10

Coverage

Newest first; wire copies grouped

Sep 2GlobeNewswireOcugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025 MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASD
Aug 13GlobeNewswireOcugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease MALVERN, Pa., Aug. 13, 20